9.050EUR+0.67%Mkt Cap: 124.00M $P/E: —1d ago
Guerbet SA provides a range of contrast media, medical devices, and digital and AI solutions for diagnostic and interventional imaging worldwide. It offers DOTAREM, a macrocyclic gadolinium-based contrast agent for use i…
Indicators:|
Key Statistics
Company
Market Cap124.00M $
Enterprise Value470.59M $
Revenue (TTM)868.12M $
Gross Profit615.42M $
Net Income (TTM)-117.75M $
Revenue/Share68.82 USD
Last Price9.050 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees2.7K
CountryFR
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)3.70
PEG0.07
EV/EBITDA9.42
EV/Revenue0.54
P/S0.14
P/B0.43
EPS (TTM)-8.91
EPS (Forward)2.44
52W Range
8.0107% of range23.70
52W High23.70 EUR
52W Low8.010 EUR
Profitability
Gross Margin70.89%
Oper. Margin-1.70%
EBITDA Margin5.76%
Profit Margin-13.56%
ROE-40.57%
ROA-11.65%
Growth
Revenue Growth-5.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF88.14M $
CapEx (TTM)39.79M $
FCF Margin9.29%
FCF Yield65.06%
Net Debt354.02M $
Net Debt/EBITDA7.08
Balance Sheet
Debt/Equity1.65
Current Ratio2.49
Quick Ratio1.08
Book Value/Sh21.16 EUR
Cash/Share9.158 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield2.65%
Payout Ratio0.00%
Ex-Div DateJul 1, 2024
Pay Date—
Splits
Last Split4:1
Split DateJan 23, 2014
Analyst Consensus
Rating—
Target (Mean)11.60 EUR
Upside (mean)+28.2%
Target Range9.000 EUR – 13.80 EUR
€9.000+28.2% to mean€13.80
# Analysts3
Ownership
Shares Out.12.61M
Float5.26M
Insiders63.21%
Institutions7.25%
Technical
SMA 5010.19 (-11.2%)
SMA 20012.65 (-28.5%)
Beta0.99
S&P 52W Chg20.05%
Avg Vol (30d)15.77K
Avg Vol (10d)19.62K
Technical Indicators
RSI (14)34.7
MACD-0.3322
MACD Signal-0.2616
MACD Hist.-0.0706
BB Upper10.77 EUR
BB Middle9.707 EUR
BB Lower8.646 EUR
BB Width21.85%
ATR (14)0.3266 EUR
Vol Ratio (20d)0.84x